Aberrant expression of <scp><i>NPPB</i></scp> through <scp>YAP1</scp> and <scp>TAZ</scp> activation in mesothelioma with Hippo pathway gene alterations
Tatsuhiro Sato(Aichi Cancer Center), Yoshitaka Sekido(Aichi Cancer Center)
Cited by 6
Related Papers
Functional differences between wild‐type and mutant‐type BRCA1‐associated protein 1 tumor suppressor against malignant mesothelioma cells
|Cancer Science|2015|35
Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively
|Cancer Cell International|2021|11
Silencing of SmgGDS, a Novel mTORC1 Inducer That Binds to RHEBs, Inhibits Malignant Mesothelioma Cell Proliferation
|Molecular Cancer Research|2021|5